IndiaInfoline on Reliance Infra - Target Rs 1160
IndiaInfoline has recommended buy rating on Reliance Infrastructure with a target of Rs 1160, in its research report.
Reliance Infra is trading 28% lower than its 52-week high of Rs1,404 in October 2009, but higher than its low of Rs45 in March 2009. A detailed study of Reliance Infra shows a distinctive pattern emerging which signals a temporary bottom. The stock has broken out (as seen in the daily chart) from the overall base-like pattern carved during the past five-weeks. In fact, the last couple of trading weeks represents a high level bullish congestion area between Rs 1,092-1,056. We believe that the current bullish consolidation is likely to lead to a potential upside, once the 50-DMA is broken. We recommend traders to buy the stock in the range of Rs 1,095-1,110 for a target of Rs 1,160. We advise traders to maintain a stop loss of Rs 1,080," says IndiaInfoline research report.
Bonanza on Jagran Prakashan - Target Rs 140
Bonanza research is bullish Jagran Prakashan and has recommended buy rating on the stock with a target of Rs 140, in its research report.
"Jagran Prakashan is among the largest print media houses in India. Its flagship brand Dainik Jagran is the largest circulation newspaper in India. The scrip is at discount to the recently concluded IPO of peer DB Corp. It is likely to show an EPS of Rs.7/Share in FY10. At CMP Rs.126/Share, it trades at 17 PE on FY10 estimates. Investors may BUY in Rs.120-122 range for a target of Rs 140 i.e. 20 PE on FY10 estimates."
Bonanza research on NHPC - Target Rs 38.
“NHPC is India’s largest Hydro Power Company. It is adding capacities at regular intervals. If Government allows it to sell power on merchant basis, its earnings can grow substantially. In the present scenario, we expect NHPC to report a consolidated EPS of Rs 1.2 per share. Its consolidated Cash EPS is likely to be Rs 2 per share. At CMP, it trades at PE of 17.8 and Cash PE of 14. The scrip had fallen sharply from its issue price of Rs 36. Share may face stiff resistance at Rs 36. The scrip is expected to appreciate steadily over a period. Long term investors may buy around current levels, for a mid term target of Rs 38.”
No comments:
Post a Comment